Partnering with Boehringer Ingelheim: new opportunities for collaboration
Partnering is a central part of our company’s strategy. We believe in working with experts outside our company to build on our prescription medicine, consumer health, contract manufacturing and animal health businesses. Partnering opportunities exist along the value chain from investments into new scientific concepts through commercial alliances.
The Global Consumer Health Business Development Team is continuously looking for innovative products and technologies to further strengthen our portfolio.
Our key areas for partnering and M&A opportunities are in the following therapeutic categories:
Cough & cold and allergy
Pain and mobility
Premium vitamin and mineral supplements
Leg health products
Furthermore we are interested in the in-licensing of Rx-to-OTC switch candidates as well as in significant growth and acquisition opportunities outside the categories listed above.